Literature DB >> 19910144

Myofibroblast distribution in Dupuytren's cords: correlation with digital contracture.

Liaquat Suleman Verjee1, Kim Midwood, Dominique Davidson, David Essex, Ann Sandison, Jagdeep Nanchahal.   

Abstract

PURPOSE: Dupuytren's tissue has typically been described as being composed of myofibroblast-rich palmar nodules and relatively acellular tendon-like cords. We aimed to determine myofibroblast distribution (alpha-smooth muscle actin [alpha-SMA] positive cells) within Dupuytren's tissue and to correlate histologically defined alpha-SMA-positive nodules with digital contracture and recurrent disease.
METHODS: One hundred and three digital Dupuytren's cords (72 fasciectomy, 31 dermofasciectomy) were stained with anti-alpha-SMA antibody. The presence of alpha-SMA-positive nodules, their surface area, and alpha-SMA-positive cells were quantified throughout excised Dupuytren's tissue. Clinical data on diathesis, flexion deformity, and previous surgeries were collected.
RESULTS: Cords were nodular (66%) or non-nodular (34%). Nodular cords contained 1 (55%), 2 (33%), or 3 or more nodules (12%) composed of localized collections of cells. The mean total nodule surface area was 23 mm(2) (range, 1.3-105 mm(2)). Nodules contained the highest number of alpha-SMA-positive cells (mean 97%, 2374 cells/mm(2)) compared to peri-nodular areas (mean 32%, 763 cells/mm(2)), and more distant cord (mean 8%, 495 cells/mm(2)). Non-nodular cords contained 9% to 17% alpha-SMA-positive cells (mean 475-663 cells/mm(2)), with higher numbers distally. There was greater digital contracture in patients with non-nodular cords. Thirty-six of 38 proximal interphalangeal (PIP) joint-marked samples had a nodule that co-localized with the PIP joint. Nodule size did not correlate with flexion deformity or with primary or recurrent disease.
CONCLUSIONS: We found that two thirds of digital cords were nodular. Nodules were hypercellular, the majority being alpha-SMA-positive cells. Nodules varied in size and co-localized with the PIP joint. Cord was relatively cellular throughout; a proportion of these cells were alpha-SMA-positive and cells aligned with collagen fibers. Non-nodular cords correlated with significantly greater digital flexion contracture. We propose that cells in nodular cords contract and deposit extracellular matrix components. The matrix is then remodeled in shortened configuration, and as fixed flexion deformity develops, stress shielding eventually leads to myofibroblast apoptosis, and cord becomes less cellular.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910144     DOI: 10.1016/j.jhsa.2009.08.005

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  21 in total

1.  Increased CCT-eta expression is a marker of latent and active disease and a modulator of fibroblast contractility in Dupuytren's contracture.

Authors:  Latha Satish; David B O'Gorman; Sandra Johnson; Christina Raykha; Bing Siang Gan; James H-C Wang; Sandeep Kathju
Journal:  Cell Stress Chaperones       Date:  2013-01-06       Impact factor: 3.667

2.  Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.

Authors:  Liaquat S Verjee; Jennifer S N Verhoekx; James K K Chan; Thomas Krausgruber; Vicky Nicolaidou; David Izadi; Dominique Davidson; Marc Feldmann; Kim S Midwood; Jagdeep Nanchahal
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-19       Impact factor: 11.205

3.  Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy.

Authors:  Syed Amir Iqbal; Christopher Manning; Farhatullah Syed; Venkatesh Kolluru; Mike Hayton; Stewart Watson; Ardeshir Bayat
Journal:  Stem Cells Dev       Date:  2011-07-19       Impact factor: 3.272

Review 4.  Collagenase Treatment in Dupuytren Contractures: A Review of the Current State Versus Future Needs.

Authors:  Ilse Degreef
Journal:  Rheumatol Ther       Date:  2016-02-03

5.  Expression of VEGF, its receptors, and HIF-1α in Dupuytren's disease.

Authors:  Lukas A Holzer; Andrej Cör; Gerhard Pfandlsteiner; Gerold Holzer
Journal:  Acta Orthop       Date:  2013-07-03       Impact factor: 3.717

6.  In vitro study of novel collagenase (XIAFLEX®) on Dupuytren's disease fibroblasts displays unique drug related properties.

Authors:  Farhatullah Syed; Alexis N Thomas; Subir Singh; Venkatesh Kolluru; Susan G Emeigh Hart; Ardeshir Bayat
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

7.  Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity.

Authors:  Alessandra Lo Cicero; Iwona Majkowska; Hideaki Nagase; Italia Di Liegro; Linda Troeberg
Journal:  Matrix Biol       Date:  2012-03-03       Impact factor: 11.583

8.  Clinical and morphological outcomes after percutaneous needle fasciotomy in Dupuytren's disease according to the contracture severity.

Authors:  Cristian Trâmbiţaş; Alina Dia Trâmbiţaş-Miron; Andrei Marian Feier; Octav Marius Russu; Dorin Constantin Dorobanţu; Klara Brînzaniuc
Journal:  Rom J Morphol Embryol       Date:  2021 Jul-Sep       Impact factor: 0.833

9.  Expression of gap junction proteins connexins 26, 30, and 43 in Dupuytren's disease.

Authors:  Lukas A Holzer; Andrej Cör; Gerold Holzer
Journal:  Acta Orthop       Date:  2013-12-20       Impact factor: 3.717

10.  First identification of resident and circulating fibrocytes in Dupuytren's disease shown to be inhibited by serum amyloid P and Xiapex.

Authors:  Syed Amir Iqbal; Michael John Hayton; James Stewart Watson; Piotr Szczypa; Ardeshir Bayat
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.